HVD Policy Task Force Comments on MCIT Repeal
Dear Administrator Brooks-LaSure: Heart Valve Voice US is submitting these comments on behalf of the Heart Valve Disease PolicyTask Force,...
Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490)
The Heart Valve Disease Policy Task Force represents a diverse group of patient,disease, and research advocacy groups with a shared...
HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies
Heart Valve Voice US is a nonprofit patient advocacy organization that provides a united voicefor people living with heart valve...
Bill Introduced to Combat Counterfeit Medical Devices
On Jan. 29, 2020, the House Energy & Commerce Committee Subcommittee on Health held a hearing on multiple bills related...
Durbin Issues Bill to Safeguard Foreign-Manufactured Medical Technology
On March 3, Sen. Dick Durbin (D-Ill.), the Senate Minority Whip, expressed his intent in a Senate floor speech to...